Literature DB >> 26107086

Proposal and content validation of an orofacial myofunctional assessment protocol for individuals with cleft lip and palate.

Andréia Fernandes Graziani1, Ana Paula Fukushiro1, Katia Flores Genaro1.   

Abstract

PURPOSE: To create and validate the content of an orofacial myofunctional assessment protocol for individuals with cleft lip and palate.
METHODS: The first version of an orofacial myofunctional assessment protocol for individuals with cleft lip and palate was created by two speech-language pathologists, who contemplated the structural and functional aspects of the stomatognathic system. This version was analyzed by other two speech-language pathologists experienced in cleft lip and palate assessment, who suggested changes that led to the second version of the protocol. Dynamic and static images necessary for performing the orofacial myofunctional examination were recorded from three individuals with cleft lip and palate, who represented three life stages: childhood, adolescence, and adulthood. Five examiners evaluated the images, applied the proposed protocol, and judged each item regarding its clarity to validate the content, from Content Validity Index.
RESULTS: The assessment protocol was finalized with 13 items, ten related to structural aspects and three related to functional aspects, with their corresponding sub-items. The general agreement in the validation of its content was 100%, so that only one stage was required.
CONCLUSION: A protocol to evaluate the orofacial myofunctional aspects of individuals with cleft lip and palate was created with 13 items, as well as their corresponding sub-items, and its content was validated.

Entities:  

Mesh:

Year:  2015        PMID: 26107086     DOI: 10.1590/2317-1782/20152014096

Source DB:  PubMed          Journal:  Codas        ISSN: 2317-1782


  1 in total

1.  Checklist for managing critical patients' daily awakening.

Authors:  Juliana Tavares de Lima; Renata Flávia Abreu da Silva; Allan Peixoto de Assis; Alexandre Silva
Journal:  Rev Bras Ter Intensiva       Date:  2019-10-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.